Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip C Robinson

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
The Lancet. Rheumatology|February 1, 2021
Divergent effects of acute versus chronic glucocorticoids in COVID-19Philip C Robinson, Eric Morand
Maturitas|June 2, 2014
Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbiditiesPhilip C Robinson, Simon Horsburgh
The Lancet. Rheumatology|June 14, 2022
Racial and ethnic differences in COVID-19 outcomes: a call to actionPhilip C Robinson, Jinoos Yazdany
Expert Opinion on Pharmacotherapy|November 7, 2017
Lesinurad for the treatment of hyperuricaemia in people with goutPhilip C Robinson, Nicola Dalbeth
The Lancet. Rheumatology|April 28, 2021
Patients with gout: an under-recognised group at high risk of COVID-19Nicola Dalbeth, Philip C Robinson
The Lancet. Diabetes & Endocrinology|July 4, 2015
Does midlife obesity really lower dementia risk?Philip C Robinson, Tony R Merriman
Australian Prescriber|October 23, 2020
Management of autoimmune disease during the COVID-19 pandemicPhilip C Robinson, , Evan C Bursle, et al.
Rheumatic Diseases Clinics of North America|October 23, 2012
The genetics of ankylosing spondylitis and axial spondyloarthritisPhilip C Robinson, Matthew A Brown
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 7, 2010
Time to treatment in rheumatoid arthritis: factors associated with time to treatment initiation and urgent triage assessment of general practitioner referralsPhilip C Robinson, William J Taylor
The Journal of Rheumatology|August 2, 2021
The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the WorldSebastian E Sattui, Philip C Robinson
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
The Lancet. Rheumatology|February 1, 2021
Divergent effects of acute versus chronic glucocorticoids in COVID-19Philip C Robinson, Eric Morand
Maturitas|June 2, 2014
Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbiditiesPhilip C Robinson, Simon Horsburgh
The Lancet. Rheumatology|June 14, 2022
Racial and ethnic differences in COVID-19 outcomes: a call to actionPhilip C Robinson, Jinoos Yazdany
Expert Opinion on Pharmacotherapy|November 7, 2017
Lesinurad for the treatment of hyperuricaemia in people with goutPhilip C Robinson, Nicola Dalbeth
The Lancet. Rheumatology|April 28, 2021
Patients with gout: an under-recognised group at high risk of COVID-19Nicola Dalbeth, Philip C Robinson
The Lancet. Diabetes & Endocrinology|July 4, 2015
Does midlife obesity really lower dementia risk?Philip C Robinson, Tony R Merriman
Australian Prescriber|October 23, 2020
Management of autoimmune disease during the COVID-19 pandemicPhilip C Robinson, , Evan C Bursle, et al.
Rheumatic Diseases Clinics of North America|October 23, 2012
The genetics of ankylosing spondylitis and axial spondyloarthritisPhilip C Robinson, Matthew A Brown
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 7, 2010
Time to treatment in rheumatoid arthritis: factors associated with time to treatment initiation and urgent triage assessment of general practitioner referralsPhilip C Robinson, William J Taylor
The Journal of Rheumatology|August 2, 2021
The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the WorldSebastian E Sattui, Philip C Robinson
Pageof 15